Skip to main content
. 2021 Mar 23;60(8):1015–1027. doi: 10.1007/s40262-021-00990-7

Fig. 2.

Fig. 2

Patient flow in the a kidney and b hepatic impairment trials. FAS full analysis set, n number of subjects, SAS safety analysis set